Full Text View
Tabular View
No Study Results Posted
Related Studies
Effects of Meditation on Mechanism of Coronary Heart Disease
This study has been completed.
Study NCT00010738   Information provided by National Center for Complementary and Alternative Medicine (NCCAM)
First Received: February 2, 2001   Last Updated: August 17, 2006   History of Changes

February 2, 2001
August 17, 2006
September 1999
 
 
 
Complete list of historical versions of study NCT00010738 on ClinicalTrials.gov Archive Site
 
 
 
Effects of Meditation on Mechanism of Coronary Heart Disease
Effects of Meditation on Mechanism of Coronary Heart Disease

To study the effects of Transcendental Meditation on Coronary Heart Disease

Recent advances in our understanding of the pathophysiology of acute cardiac events - specifically, identification of the roles that arterial vasomotor dysfunction and autonomic nervous system imbalances play in the pathophysiologic cascade during such acute events - provides a platform for new mechanistic investigation of the interplay of psychosomatic stress and CHD (coronary heart disease). Preliminary evidence further suggests that Complementary and Alternative Medicine (CAM) practices, such as the Transcendental Meditation (TM) technique, can not only reduce stress but also reduce acute cardiac events in patients with CHD. Based on these and related data, we propose a randomized, blinded, controlled study of the effects of one CAM practice, the TM technique, compared to a control group, on the primary outcomes of (1) arterial vasomotor dysfunction (brachial artery reactivity); (2) autonomic nervous system imbalances (heart rate variability); (3) transient myocardial ischemia (ST-segment depression); and (4) the secondary outcomes of psychological stress and quality of life (anger, hostility, anxiety, depression, perceived health, disease-specific symptoms, and life stress/social resources).

Phase II
Interventional
Treatment, Randomized
Coronary Heart Disease
Procedure: Meditation
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
145
August 2002
 

Inclusion Criteria:

  • Able to attend training sessions and meetings
  • Local residence

Exclusion Criteria:

  • Comorbid disease precluding survival in group
  • MI, unstable angina, CABG or PTCA within last three months.
  • Cognitive/psychological/substance abuse impairment
  • Atrial fibrillation, predominant pacemaker rhythm or significant conduction system disease
  • Significant valvular heart disease
  • Class III or IV heart failure
  • Renal failure
  • Participating in a formal stress management program
  • Participation in another trial
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00010738
 
R01 AT000226-01M, R01 AT000226-01
National Center for Complementary and Alternative Medicine (NCCAM)
 
Principal Investigator: C. Noel Bairey Merz, M.D. Preventive and Rehabilitative Cardiac Center
National Center for Complementary and Alternative Medicine (NCCAM)
July 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP